Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 16

1.

A natural variant type II G protein-coupled receptor for vasoactive intestinal peptide with altered function.

Grinninger C, Wang W, Oskoui KB, Voice JK, Goetzl EJ.

J Biol Chem. 2004 Sep 24;279(39):40259-62. Epub 2004 Aug 9.

2.

VIP/PACAP preferentially attract Th2 effectors through differential regulation of chemokine production by dendritic cells.

Delgado M, Gonzalez-Rey E, Ganea D.

FASEB J. 2004 Sep;18(12):1453-5. Epub 2004 Jul 1.

PMID:
15231725
3.

c-Maf and JunB mediation of Th2 differentiation induced by the type 2 G protein-coupled receptor (VPAC2) for vasoactive intestinal peptide.

Voice J, Donnelly S, Dorsam G, Dolganov G, Paul S, Goetzl EJ.

J Immunol. 2004 Jun 15;172(12):7289-96.

4.

The significance of vasoactive intestinal peptide in immunomodulation.

Delgado M, Pozo D, Ganea D.

Pharmacol Rev. 2004 Jun;56(2):249-90. Review.

5.
6.

Immunoeffector and immunoregulatory activities of vasoactive intestinal peptide.

Voice JK, Dorsam G, Chan RC, Grinninger C, Kong Y, Goetzl EJ.

Regul Pept. 2002 Nov 15;109(1-3):199-208. Review.

PMID:
12409234
7.

Enhanced delayed-type hypersensitivity and diminished immediate-type hypersensitivity in mice lacking the inducible VPAC(2) receptor for vasoactive intestinal peptide.

Goetzl EJ, Voice JK, Shen S, Dorsam G, Kong Y, West KM, Morrison CF, Harmar AJ.

Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13854-9. Epub 2001 Nov 6.

8.
9.

Cutting edge: is vasoactive intestinal peptide a type 2 cytokine?

Delgado M, Ganea D.

J Immunol. 2001 Mar 1;166(5):2907-12.

10.

Vasoactive intestinal peptide mediation of development and functions of T lymphocytes.

Dorsam G, Voice J, Kong Y, Goetzl EJ.

Ann N Y Acad Sci. 2000;921:79-91. Review.

PMID:
11193882
11.

Selective gene expression and activation-dependent regulation of vasoactive intestinal peptide receptor type 1 and type 2 in human T cells.

Lara-Marquez M, O'Dorisio M, O'Dorisio T, Shah M, Karacay B.

J Immunol. 2001 Feb 15;166(4):2522-30.

12.

Regulation of VIP production and secretion by murine lymphocytes.

Martinez C, Delgado M, Abad C, Gomariz RP, Ganea D, Leceta J.

J Neuroimmunol. 1999 Jan 1;93(1-2):126-38.

PMID:
10378876
13.

Differential expression of vasoactive intestinal peptide receptors 1 and 2 (VIP-R1 and VIP-R2) mRNA in murine lymphocytes.

Delgado M, Martinez C, Johnson MC, Gomariz RP, Ganea D.

J Neuroimmunol. 1996 Aug;68(1-2):27-38.

PMID:
8784257
14.

Specific recognition of the human neuroendocrine receptor for vasoactive intestinal peptide by anti-peptide antibodies.

Goetzl EJ, Patel DR, Kishiyama JL, Smoll AC, Turck CW, Law NM, Rosenzweig SA, Sreedharan SP.

Mol Cell Neurosci. 1994 Apr;5(2):145-52.

PMID:
7518311
15.

Vasoactive intestinal peptide stimulates T lymphocytes to release IL-5 in murine schistosomiasis mansoni infection.

Mathew RC, Cook GA, Blum AM, Metwali A, Felman R, Weinstock JV.

J Immunol. 1992 Jun 1;148(11):3572-7.

PMID:
1588046
16.

Peptidolytic monoclonal antibody elicited by a neuropeptide.

Paul S, Sun M, Mody R, Tewary HK, Stemmer P, Massey RJ, Gianferrara T, Mehrotra S, Dreyer T, Meldal M, et al.

J Biol Chem. 1992 Jul 5;267(19):13142-5.

Supplemental Content

Support Center